International Agency for Research on Cancer. WHO Classification of Tumours Editorial Board - Breast Tumours. 5e éd. IARC Publications; 2019: 43‐46.
2.
HayesMM. Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation. J Clin Pathol. 2011;64:477‐484.
3.
GinterPSMcIntirePJKurtisB, et al.Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity. Mod Pathol. 2020;33:1764‐1772.
4.
GeyerFCLiAPapanastasiouAD, et al.Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas. Nat Commun. 2018;9:1816.
5.
CondorelliRMoseleFVerretB, et al.Genomic alterations in breast cancer: level of evidence for actionability according to ESMO scale for clinical actionability of molecular targets (ESCAT). Ann Oncol. 2019;30:365‐373.
6.
WalshMDBuchananDDCummingsMC, et al.Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010;16:2214‐2224.